VIVO Protocol: Feasibility of Merging VIVO with inHEART

Date Added
December 23rd, 2020
PRO Number
Pro00094238
Researcher
Michael Gold

List of Studies


Keywords
Cardiovascular
Summary

The purpose of the study is to give more information about how the VIVO software and inHEART software merge together and what potential benefits this could provide the physician for planning ablation procedures. In addition, the study will also provide information about the accuracy of VIVO in varying degrees of damaged hearts.

Institution
MUSC
Recruitment Contact
Deborah Everidge
843-792-2244
adamsde@musc.edu

SyncAV Post-Market Trial Clinical Plan

Date Added
November 24th, 2020
PRO Number
Pro00104639
Researcher
Michael Gold

List of Studies


Keywords
Heart
Summary

The purpose of this research study is to evaluate a different way to program a Cardiac Resynchronization Therapy Defibrillator (CRT-D) through the use of software built into the CRT-D system. A CRT-D does not cure heart failure, but many people who receive a CRT device note that they feel better. The objective of the device programming required by the study is to see if it reduces the size of the heart and make the heart pump more effectively.

Institution
MUSC
Recruitment Contact
Deborah Everidge
843-792-2944
adamsde@musc.edu

Apixaban for the Reduction of Thrombo-Embolism in patients with Device-Detected Sub-Clinical Atrial fibrillation

Date Added
June 27th, 2017
PRO Number
Pro00067386
Researcher
Michael Gold

List of Studies


Keywords
Cardiovascular
Summary

The purpose of this study is to determine which treatment is best for preventing stroke or systemic embolism in patients who have experienced at least one episode of SCAF (sub-clinical atrial fibrillation) detected by their pacemaker or ICD (intracardiac defibrillator) or ICM (insertable cardiac monitor) and also have other risk factors for stroke. Subjects will be randomly assigned to one of the two treatment strategies: apixaban or aspirin. Neither the subject nor the researcher will know which treatment the subject is assigned. Follow-up visits will occur every six months until the end of the study.

Institution
MUSC
Recruitment Contact
Deborah Everidge
843-792-2944
adamsde@musc.edu



-- OR --